Alvotech and Dr. Reddy’s collaborate for commercialization of AVT03 (denosumab)
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)
Updated results from the four studies will be presented in Oral Reports or Posters at the ASCO Annual Meeting
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
Dexamethasone Tablets USP, 1 mg had annual sales of US$ 1.8 mn in the United States (IQVIA MAT March 24)
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases
Subscribe To Our Newsletter & Stay Updated